| Description |
1 online resource (288 p.) |
| Contents |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Advances in Pulmonary Nanopharmacology -- Khadijeh Khezri1, Solmaz Maleki Dizaj2,* and Shahriar Shahi2 -- INTRODUCTION -- THE RESPIRATORY TRACT -- NANOPHARMACOLOGY -- Methods for Evaluation of Pulmonary Drug Delivery Systems -- Factors Influencing Pulmonary Drug Absorption -- The Type of Inhaler Devices -- Excipients as Strategies for the Development of Pulmonary Formulations -- Innovative Strategies for Pulmonary Drug Delivery -- Prodrugs -- Microparticles |
|
Smart Bio-Responsive Systems -- NANOMEDICINES AS A PROMISING STRATEGY FOR THE MANAGEMENT OF RESPIRATORY DISEASES -- Interactions of Nanoparticles with pulmonary Structures and Cellular Responses -- Recent Advances in the Diagnosis and Treatment of Lung Diseases Using Nanotechnology -- Lung Cancer -- CYSTIC Fibrosis (CF) -- CONCLUSION AND THE FUTURE OUTLOOK -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Advances in Cardiovascular Nanopharmacology -- Solmaz Maleki Dizaj1,*, Shahriar Shahi1, Khadijeh Khezri2 and Simin Sharifi1 -- INTRODUCTION |
|
CUTTING-EDGE NANOTECHNOLOGY FOR CVD THERAPY -- A REVIEW ON RECENT STUDIES ON NANOTECHNOLOGY IN CARDIOVASCULAR DISEASES -- Applying Nanotechnology in Hypertensive Disease -- Advances in Nanotechnology in Atherosclerosis and Hyperlipidemia -- Pulmonary Hypertension and Nanotechnology -- Treatment of Acute Myocardial Infarction with Nanotechnology -- Using Nanomedicine in the Treatment of Stroke -- Treating Thrombosis by the Use of Nanotechnology -- Nano-coating of CVDs Devices -- TOXICITY OF NANOMATERIALS IN CARDIOVASCULAR APPLICATIONS -- CONCLUSION AND THE FUTURE PERSPECTIVE |
|
CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Advances in Nanopharmacology: Cancer Treat- ment -- Soheila Montazersaheb1, Raheleh Farahzadi2,* and Afsaneh Farjami3,4,* -- INTRODUCTION -- Nanomedicine: A Review on Nanotechnology for Cancer Therapy -- Nanomedicine for Angiogenesis in Cancer -- Advances of Nanotechnology in Hematological Malignancies -- Acute Myeloid Leukemia -- Acute Lymphoblastic Leukemia -- Chronic Myeloid Leukemia -- Anaplastic Large Cell Lymphoma -- Application of Nanotechnology in Solid Tumors -- Breast Cancer -- Colorectal Cancer |
|
Lung Cancer -- Prostate Cancer -- CONCLUSION AND THE FUTURE OUTLOOK -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES -- Nanomedicine in Nephrology and Urinary Tract Infection -- Sepideh Zununi Vahed1, Mohammadreza Ardalan1 and Yalda Rahbar Saadat1,* -- INTRODUCTION -- Drug Delivery, Pharmacokinetics, and Safety of Nanodrugs -- NPs can Target Kidney Tissue -- Approved Nanodrugs in Nephrology -- Mircera®/Methoxy Polyethylene Glycol-epoetin Beta -- Renagel®[Sevelamer Hydrochloride]/ Renvela®[Sevelamer Carbonate] -- INFeD® / Dexferrum® -- Feraheme™/Ferumoxytol |
| Summary |
This book explains key concepts and applications of nanotechnology in clinical medicine and pharmacology. The chapters have been contributed by experts and provide a broad perspective about the current and future developments in pharmacology, toxicology, cell biology, and materials science. The book is divided into 2 main sections. The first section concerns nanobiotechnology for human health including gastrointestinal disease, kidney diseases, pulmonary disor |
| Notes |
Description based upon print version of record |
|
Venofer® |
| Form |
Electronic book
|
| Author |
Cucchiarini, Magali
|
|
Eftekhari, Aziz
|
| ISBN |
9789815079692 |
|
9815079697 |
|
